Elevated Dnmt3a Activity Promotes Polyposis in ApcMin Mice by Relaxing Extracellular Restraints on Wnt Signaling

Gastroenterology

Volumn 137, Issue 3, 2009, Pages

  Samuel, Michael S ^a   Suzuki, Hiromu ^b   Buchert, Michael ^a   Putoczki, Tracy L ^a   Tebbutt, Niall C ^a   Lundgren May, Therése ^a   Christou, Aliki ^a   Inglese, Melissa ^a   Toyota, Minoru ^b   Heath, Joan K ^a   Ward, Robyn L ^c   Waring, Paul M ^a   Ernst, Matthias ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

A33 GLYCOPROTEIN; APC PROTEIN; BETA CATENIN; DNA METHYLTRANSFERASE 3A; GLYCOPROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG; WNT PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXIN2 GENE; CARCINOGENESIS; COLON POLYPOSIS; CONTROLLED STUDY; EMBRYO; GENE LOSS; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC CORRELATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SFRP5 GENE; TRANSGENE; WILD TYPE;

EID: 69249091869     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.05.042     Document Type: Article

References (49)

1. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 (2002) 415-428
2. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat Genet 21 (1999) 163-167
3. el-Deiry W.S., Nelkin B.D., Celano P., et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A 88 (1991) 3470-3474
4. Feinberg A.P., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
5. Issa J.P. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol 249 (2000) 101-118
6. Baylin S.B., Hoppener J.W., de Bustros A., et al. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res 46 (1986) 2917-2922
7. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
8. Lin H., Yamada Y., Nguyen S., et al. Suppression of intestinal neoplasia by deletion of Dnmt3b. Mol Cell Biol 26 (2006) 2976-2983
9. Wu J., Issa J.P., Herman J., et al. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc Natl Acad Sci U S A 90 (1993) 8891-8895
10. Chan A.O., and Rashid A. CpG island methylation in precursors of gastrointestinal malignancies. Curr Mol Med 6 (2006) 401-408
11. Suzuki H., Gabrielson E., Chen W., et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31 (2002) 141-149
12. Schmidt W.M., Sedivy R., Forstner B., et al. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog 46 (2007) 766-772
13. Bestor T.H. Unanswered questions about the role of promoter methylation in carcinogenesis. Ann N Y Acad Sci 983 (2003) 22-27
14. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
15. Sancho E., Batlle E., and Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20 (2004) 695-723
16. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
17. Kawano Y., and Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116 (2003) 2627-2634
18. Ward R.L., Turner J., Williams R., et al. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 207 (2005) 377-384
19. Frommer M., McDonald L.E., Millar D.S., et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89 (1992) 1827-1831
20. Johnstone C.N., Tebbutt N.C., Abud H.E., et al. Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells. Am J Physiol GastrointestLiver Physiol 279 (2000) G500-G510
21. Lakso M., Pichel J.G., Gorman J.R., et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A 93 (1996) 5860-5865
22. Welt S., Divgi C.R., Real F.X., et al. Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33. J Clin Oncol 8 (1990) 1894-1906
23. Esteller M., Sparks A., Toyota M., et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60 (2000) 4366-4371
24. Suzuki H., Watkins D.N., Jair K.W., et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36 (2004) 417-422
25. Nathke I.S., Adams C.L., Polakis P., et al. The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J Cell Biol 134 (1996) 165-179
26. Sansom O.J., Meniel V.S., et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 446 (2007) 676-679
27. Turker M.S. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21 (2002) 5388-5393
28. Menschikowski M., Hagelgans A., Gussakovsky E., et al. Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms. Neoplasia 10 (2008) 279-286
29. Linhart H.G., Lin H., Yamada Y., et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21 (2007) 3110-3122
30. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
31. Niida A., Hiroko T., Kasai M., et al. DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway. Oncogene 23 (2004) 8520-8526
32. Jho E., Zhang T., Domon C., et al. Wnt/β-catenin/TcF signaling induces the transcription of axin-2, a negative regulator of the signaling pathway. Mol Cell Biol 22 (2002) 1172-1183
33. Li Q., Ishikawa T.O., Oshima M., et al. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Cancer Res 65 (2005) 8622-8627
34. Fuks F., Burgers W.A., Godin N., et al. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 20 (2001) 2536-2544
35. Abud H.E., Johnstone C.N., Tebbutt N.C., et al. The murine A33 antigen is expressed at two distinct sites during development, the ICM of the blastocyst and the intestinal epithelium. Mech Dev 98 (2000) 111-114
36. Costello J.F., and Plass C. Methylation matters. J Med Genet 38 (2001) 285-303
37. Chan T.A., Glockner S., Yi J.M., et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med 5 (2008) e114
38. Yan H., Dobbie Z., Gruber S.B., et al. Small changes in expression affect predisposition to tumorigenesis. Nat Genet 30 (2002) 25-26
39. Aguilera O., Fraga M.F., Ballestar E., et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25 (2006) 4116-4121
40. Barker N., Ridgway R.A., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457 (2009) 608-611
41. Sabates-Bellver J., Van der Flier L.G., de Palo M., et al. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5 (2007) 1263-1275
42. Gregorieff A., Pinto D., Begthel H., et al. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129 (2005) 626-638
43. Kanai Y., and Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28 (2007) 2434-2442
44. Schmidt W.M., Sedivy R., Forstner B., et al. Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequence. Mol Carcinog 46 (2007) 766-772
45. Gokul G., Gautami B., Malathi S., et al. DNA methylation profile at the DNMT3L promoter: a potential biomarker for cervical cancer. Epigenetics 2 (2007) 80-85
46. Fabbri M., Garzon R., Cimmino A., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104 (2007) 15805-15810
47. Ostler K.R., Davis E.M., Payne S.L., et al. Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene 26 (2007) 5553-5563
48. Gowher H., Stuhlmann H., and Felsenfeld G. Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b. Genes Dev 22 (2008) 2075-2084
49. Stresemann C., Brueckner B., Musch T., et al. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res 66 (2006) 2794-2800